| David M Steiman, MD | |
|
350 Nw 84th Ave Ste 211, Plantation, FL 33324-1859 | |
| (954) 236-8511 | |
| Not Available |
| Full Name | David M Steiman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 350 Nw 84th Ave Ste 211, Plantation, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619084456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | ME68096 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westside Regional Medical Center | Plantation, FL | Hospital |
| Holy Cross Hospital | Fort lauderdale, FL | Hospital |
| Broward Health Medical Center | Fort lauderdale, FL | Hospital |
| Memorial Hospital West | Pembroke pines, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ekg And Echo Readers Inc | 4082688718 | 23 |
| David Steiman Md Pa | 9830267251 | 2 |
News Archive
A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.
STENTYS S.A., a medical technology company commercializing the world's first and only Self-Apposing Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its 'APPOSITION IV' clinical study using its new Self-Apposing Sirolimus-eluting stent.
The COVID-19 pandemic triggered life expectancy losses not seen since World War II in Western Europe and exceeded those observed around the dissolution of the Eastern Bloc in central and Eastern European countries.
CyDex Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to CyDex entitled "Sulfoalkyl Ether Cyclodextrin Compositions." This patent, along with other previously issued technology patents, will provide broad protection for CyDex's Captisol® technology until 2029.
› Verified 8 days ago
| Entity Name | Ekg & Echo Readers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245284389 PECOS PAC ID: 4082688718 Enrollment ID: O20040819001271 |
News Archive
A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.
STENTYS S.A., a medical technology company commercializing the world's first and only Self-Apposing Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its 'APPOSITION IV' clinical study using its new Self-Apposing Sirolimus-eluting stent.
The COVID-19 pandemic triggered life expectancy losses not seen since World War II in Western Europe and exceeded those observed around the dissolution of the Eastern Bloc in central and Eastern European countries.
CyDex Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to CyDex entitled "Sulfoalkyl Ether Cyclodextrin Compositions." This patent, along with other previously issued technology patents, will provide broad protection for CyDex's Captisol® technology until 2029.
› Verified 8 days ago
| Entity Name | David Steiman Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790942720 PECOS PAC ID: 9830267251 Enrollment ID: O20081011000003 |
News Archive
A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.
STENTYS S.A., a medical technology company commercializing the world's first and only Self-Apposing Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its 'APPOSITION IV' clinical study using its new Self-Apposing Sirolimus-eluting stent.
The COVID-19 pandemic triggered life expectancy losses not seen since World War II in Western Europe and exceeded those observed around the dissolution of the Eastern Bloc in central and Eastern European countries.
CyDex Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to CyDex entitled "Sulfoalkyl Ether Cyclodextrin Compositions." This patent, along with other previously issued technology patents, will provide broad protection for CyDex's Captisol® technology until 2029.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David M Steiman, MD 350 Nw 84th Ave Ste 211, Plantation, FL 33324-1859 Ph: (954) 236-8511 | David M Steiman, MD 350 Nw 84th Ave Ste 211, Plantation, FL 33324-1859 Ph: (954) 236-8511 |
News Archive
A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.
STENTYS S.A., a medical technology company commercializing the world's first and only Self-Apposing Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its 'APPOSITION IV' clinical study using its new Self-Apposing Sirolimus-eluting stent.
The COVID-19 pandemic triggered life expectancy losses not seen since World War II in Western Europe and exceeded those observed around the dissolution of the Eastern Bloc in central and Eastern European countries.
CyDex Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to CyDex entitled "Sulfoalkyl Ether Cyclodextrin Compositions." This patent, along with other previously issued technology patents, will provide broad protection for CyDex's Captisol® technology until 2029.
› Verified 8 days ago
Dr. Hussein Al Dabbagh, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8201 W Broward Blvd, Plantation, FL 33324 Phone: 954-829-0639 | |
Dr. Elliot Mark Wortzel, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 201 Nw 82 Ave, Suite 305, Plantation, FL 33324 Phone: 954-473-5303 Fax: 954-473-5406 | |
Mr. Ajaib S Mann Sr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1806 North Pine Island Rd, Plantation, FL 33322 Phone: 954-474-0110 Fax: 954-424-9859 | |
Dr. Gerardo S. Lanes, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 140 Sw 84th Ave, Suite C, Plantation, FL 33324 Phone: 954-476-9350 Fax: 954-476-2446 | |
Dr. Mohammed I Baig, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 S Hospital Dr, Ste 300, Plantation, FL 33317 Phone: 954-797-0601 Fax: 954-797-1466 | |
Allen Robert Sklaver, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7353 Nw 4th St, Plantation, FL 33317 Phone: 954-584-6320 Fax: 954-587-2166 | |
Cesar Ochoa Perez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1228 S Pine Island Rd Ste 410, Plantation, FL 33324 Phone: 954-837-1490 Fax: 954-837-1188 |